Last quarter (Q ), Eifelhoehen-Klinik AG's total revenue was €―, a decrease of ― from the same quarter last year. In Q, Eifelhoehen-Klinik AG's net income was €―. See Eifelhoehen-Klinik AG’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	-	€ 35.80M	€ 35.48B	€ 48.45M	€ 49.32M	€ 46.94M
Cost of Revenue	-	€ 7.35M	€ 6.76B	€ 8.56M	€ 8.63M	€ 8.03M
Gross Profit	-	€ 28.46M	€ 28.72B	€ 39.89M	€ 40.69M	€ 38.91M
Operating Expense	-	€ 28.98M	€ 28.82B	€ 37.28M	€ 39.88M	€ 38.55M
Operating Income	-	€ -520.50K	€ -96.19M	€ 2.61M	€ 811.92K	€ 360.90K
Net Non Operating Interest Income Expense	-	€ -2.94M	€ -2.56B	€ -2.88M	€ -823.64K	€ -606.24K
Other Income Expense	-	-	-	-	-	-
Pretax Income	-	€ -4.10M	€ -1.19B	€ -74.96K	€ -597.42K	€ 6.52K
Tax Provision	-	€ 117.34K	€ 118.72M	€ 606.83K	€ 444.91K	€ 92.60K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	€ -4.40M	€ -1.42B	€ -773.32K	€ -1.11M	€ -114.40K
Basic EPS	-	€ -1.46	€ -0.47	€ -0.26	€ -0.37	€ -0.04
Diluted EPS	-	€ -1.46	€ -0.47	€ -0.26	€ -0.37	€ -0.04
Basic Average Shares	-	€ 3.02M	€ 3.02M	€ 3.02M	€ 3.02M	€ 3.02M
Diluted Average Shares	-	€ 3.02M	€ 3.02M	€ 3.02M	€ 3.02M	€ 3.02M
Dividend Per Share	-	€ 0.00	€ 0.00	€ 0.00	€ 0.00	€ 0.41
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	€ 219.00K	€ 165.00M	€ 276.00K	€ 4.80M	€ 4.76M
Total Expenses	-	€ 36.32M	€ 35.57B	€ 45.85M	€ 48.51M	€ 46.58M
Net Income From Continuing And Discontinued Operation	-	€ -4.40M	€ -1.42B	€ -773.32K	€ -1.11M	€ -114.40K
Normalized Income	-	€ -3.95M	€ -2.44B	€ -913.51K	€ -700.75K	€ -291.33K
Interest Expense	-	€ 2.94M	€ 2.57B	€ 2.88M	€ 825.04K	€ 631.00K
EBIT	-	€ -1.16M	€ 1.38B	€ 2.81M	€ 227.62K	€ 637.52K
EBITDA	-	€ 3.22M	€ 6.47B	€ 8.63M	€ 2.39M	€ 2.59M

Currency in EUR

Eifelhoehen-Klinik AG Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing